OXLC’s RIC structure forces high payouts but erodes NAV, making long-term buy-and-hold strategies risky and often ...

Jazz Pharmaceuticals plc is a Buy with its robust portfolio, potential FDA approvals, and innovative oncology treatments.

Labour's inheritance tax raid on non-doms is being blamed for the projected 'millionaire exodus' expected to hit the UK ...